Prothena | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
ALKERMES USD 165.05M 163.25M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amgen USD 538M 33.04B 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Exelixis USD 270.13M 269.86M 2025-07
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
MacroGenics USD 628K 1000 2024-12
Neurocrine Biosciences USD 99M 0 2025-06
Prothena USD 538K 0 2024-12
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Prothena Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.